Results 91 to 100 of about 39,988 (211)

RESTORATION OF MOTOR AND NON-MOTOR FUNCTIONS BY NEUROTROPHIC FACTORS IN NONHUMAN PRIMATES WITH DOPAMINE DEPLETION [PDF]

open access: yes, 2013
Parkinson’s disease (PD) is a progressive debilitating neurodegenerative disorder characterized by resting tremor, rigidity, bradykinesia and postural instability. As the disease progresses there is a loss of dopamine (DA) neurons in the substantia nigra
Subramanian, Krishna
core  

The c-Abl inhibitor INNO-406 protects against MPTP-induced loss of DA neurons.

open access: yes, 2013
INNO-406 (10 mg/kg/i.p for one week prior to MPTP, 4×20 mg, and one week after MPTP treatment) protects (A–D) substantia nigra DA neurons and (E–H) striatal DA terminals from MPTP-induced toxicity.
Shinya Kimura (247648)   +8 more
core   +1 more source

SPC from N-4YSyn immunized B10.BR mice exacerbate MPTP-induced dopaminergic neurodegeneration and induce microglial responses in the SNpc.

open access: yes, 2013
Photomicrographs from VMB sections stained with Fluoro-Jade C (left and middle panels) and Mac-1 antibody (right panels). PBS controls (PBS/none) exhibit an absence of Fluoro-Jade C stained dead neurons on days 2 and 7, and only faint Mac-1 ...
Ashley D. Reynolds (37627)   +10 more
core   +1 more source

IN19-mediated neuroprotection in a chronic MPTP/P injection model.

open access: yes, 2012
A, The effect of IN19 on neurodegeneration after MPTP/P injections. Brain sections, including the SN (upper row) or CPu (lower row), from wild-type mice that were injected or not injected with MPTP/P, in the presence or absence of IN19, were ...
Hirofumi Sudo (125003)   +8 more
core   +1 more source

Differential Effects of Carboxyfullerene on Mpp+/Mptp-Induced Neurotoxicity

open access: yes, 2009
The effects of carboxyfullerene on a well-known neurotoxin, 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its active metabolite 1- methyl-4-phenyl-pyridinium (MPP+) were investigated. In chloral hydrate- anesthetized rats, cytosolic cytochrome
LIN, MAAN-YUH;YANG, CHIH-HSIN   +1 more
core  

Angiogenin does not prevent MPTP-induced depletion of dopamine and its metabolites in the striatum.

open access: yes, 2013
Three weeks after MPTP or saline injections, AAV2-GFP and AAV2-Ang-injected mice were sacrificed and striatal tissue immediately removed and frozen for HPLC. DA and its metabolites, DOPAC and HVA, were analyzed by HPLC.
Trent U. Steidinger (284605)   +4 more
core   +1 more source

The Role of Mitochondrial Permeability Transition in Bone Metabolism, Bone Healing, and Bone Diseases

open access: yesBiomolecules
Bone is a dynamic organ with an active metabolism and high sensitivity to mitochondrial dysfunction. The mitochondrial permeability transition pore (mPTP) is a low-selectivity channel situated in the inner mitochondrial membrane (IMM), permitting the ...
Xiting Zhu   +6 more
doaj   +1 more source

Comparison of the intranasal and intraperitoneal injection of MPTP on density of dark neurons in pars compacta of substantia nigra in animal model of Parkinson\'s disease

open access: yesمجله دانشگاه علوم پزشکی گرگان, 2015
Background and Objective: Parkinson disease (PD) is the second most common neurologic disorder that results following degeneration of dopaminergic neurons in the pars compacta of substintia nigra (SNc). The 1-methyl-1,2,3,6-tetrahydropiridine (MPTP) is a
Shahi S   +5 more
doaj  

Evidence of Increased nNOS Activity in Acute MPTP Neurotoxicity: A Functional Pharmacological MRI Study

open access: yes, 2020
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a neurotoxin commonly used to produce an animal model of Parkinson's disease. Previous studies have suggested a critical role for neuronal nitric oxide (NO) synthase-(nNOS-) derived NO in the ...
Kai-Ping N Chow   +4 more
core  

Home - About - Disclaimer - Privacy